tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AXSM Stock Latest News

Axsome Therapeutics: Strong Commercial Performance and Strategic Growth Initiatives Drive Buy Rating
RatingsAxsome Therapeutics: Strong Commercial Performance and Strategic Growth Initiatives Drive Buy Rating
3h ago
AXSM
Axsome Therapeutics price target raised to $200 from $190 at H.C. Wainwright
PremiumThe Fly
Axsome Therapeutics price target raised to $200 from $190 at H.C. Wainwright
3h ago
AXSM
Axsome Therapeutics price target raised to $200 from $190 at Truist
PremiumThe Fly
Axsome Therapeutics price target raised to $200 from $190 at Truist
1d ago
AXSM
Axsome Therapeutics price target raised to $192 from $143 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target raised to $192 from $143 at RBC Capital
1d ago
AXSM
Axsome Therapeutics price target raised to $153 from $133 at Needham
PremiumThe Fly
Axsome Therapeutics price target raised to $153 from $133 at Needham
1d ago
AXSM
Positive Outlook for Axsome Therapeutics Amid Key Developments and Growth Potential
PremiumRatingsPositive Outlook for Axsome Therapeutics Amid Key Developments and Growth Potential
1d ago
AXSM
Promising Growth and Market Expansion Drive Buy Rating for Axsome Therapeutics
Premium
Ratings
Promising Growth and Market Expansion Drive Buy Rating for Axsome Therapeutics
1d ago
AXSM
Axsome Therapeutics price target raised to $195 from $135 at Guggenheim
Premium
The Fly
Axsome Therapeutics price target raised to $195 from $135 at Guggenheim
1d ago
AXSM
Axsome Therapeutics Sees Robust Growth and Strategic Progress
PremiumCompany Announcements
Axsome Therapeutics Sees Robust Growth and Strategic Progress
1d ago
AXSM
Axsome Therapeutics Inc. Earnings Report: Is it a Beat?
PremiumEarning Releases
Axsome Therapeutics Inc. Earnings Report: Is it a Beat?
2d ago
AXSM
Axsome Therapeutics’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Axsome Therapeutics’ Earnings Call: Growth Amid Challenges
2d ago
AXSM
Axsome Therapeutics: Strong Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
Axsome Therapeutics: Strong Performance and Promising Pipeline Justify Buy Rating
2d ago
AXSM
Axsome Therapeutics reports Q4 EPS ($1.54), consensus ($1.00)
PremiumThe FlyAxsome Therapeutics reports Q4 EPS ($1.54), consensus ($1.00)
2d ago
AXSM
Axsome Therapeutics expects cash to fund operations into cash flow positivity
Premium
The Fly
Axsome Therapeutics expects cash to fund operations into cash flow positivity
2d ago
AXSM
Options Volatility and Implied Earnings Moves Today, February 18, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, February 18, 2025
2d ago
IQ
DVN
Is AXSM a Buy, Before Earnings?
PremiumPre-Earnings
Is AXSM a Buy, Before Earnings?
4d ago
AXSM
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
8d ago
AXSM
BDRX
Axsome Therapeutics price target raised to $160 from $140 at Wells Fargo
PremiumThe Fly
Axsome Therapeutics price target raised to $160 from $140 at Wells Fargo
8d ago
AXSM
Axsome Therapeutics price target raised to $167 from $143 at BofA
PremiumThe Fly
Axsome Therapeutics price target raised to $167 from $143 at BofA
9d ago
AXSM
Axsome Therapeutics price target raised to $195 from $137 at Mizuho
PremiumThe FlyAxsome Therapeutics price target raised to $195 from $137 at Mizuho
9d ago
AXSM
TD ups Axsome target, sees takeout speculation on patent settlement
Premium
The Fly
TD ups Axsome target, sees takeout speculation on patent settlement
9d ago
AXSM
TEVA
Axsome Therapeutics initiated with a Buy at Deutsche Bank
Premium
The Fly
Axsome Therapeutics initiated with a Buy at Deutsche Bank
9d ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >